We are live on
!
Find out more
CAPTRUST Financial Advisors Portfolio holdings
AUM
$57.3B
1-Year Est. Return
18.32%
This Fund
S&P 500
This Quarter
Est. Return
-0.88%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$39.9B
AUM Growth
+$4.85B
(+14%)
Cap. Flow
+$5.66B
Cap. Flow
% of AUM
14.2%
Top 10 Holdings %
Top 10 Hldgs %
25.25%
Holding
2,479
New
188
Increased
1,256
Reduced
810
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$362M |
| 2 |
Apple
AAPL
|
+$220M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Watsco Inc
WSO
|
+$165M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$67.6M |
| 2 |
Nucor
NUE
|
+$67.3M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$64.1M |
| 4 |
Tesla
TSLA
|
+$49.1M |
| 5 |
Amgen
AMGN
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.07% |
| 2 | Financials | 8.19% |
| 3 | Healthcare | 5.47% |
| 4 | Industrials | 4.86% |
| 5 | Consumer Discretionary | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Clean Energy Fuels
CLNE
$447M
| $15.5K | ﹤0.01% |
+10,021
| New | +$25.5K |
|
|
IGMS
2327
DELISTED
IGM Biosciences
IGMS
| $15.3K | ﹤0.01% |
13,308
+3,107
| +30% | +$5.78K |
|
2328
Lexicon Pharmaceuticals
LXRX
$1.02B
| $15.3K | ﹤0.01% |
33,184
+19,826
| +148% | +$12.5K |
|
2329
AN2 Therapeutics
ANTX
$177M
| $13.6K | ﹤0.01% |
10,000
-18,667
| -65% | -$23.5K |
|
2330
Fate Therapeutics
FATE
$281M
| $13K | ﹤0.01% |
+16,429
| New | +$20.1K |
|
|
FRSX
2331
Foresight Autonomous Holdings
FRSX
$4.02M
| $12.9K | ﹤0.01% |
+964
| New | +$19.8K |
|
|
CGC
2332
Canopy Growth
CGC
$375M
| $12.2K | ﹤0.01% |
13,387
-282
| -2% | -$496 |
|
2333
GoPro
GPRO
$116M
| $11.6K | ﹤0.01% |
+17,423
| New | +$15.4K |
|
|
MRSN
2334
DELISTED
Mersana Therapeutics
MRSN
| $10.7K | ﹤0.01% |
+1,245
| New | +$19.2K |
|
2335
Stem
STEM
$49.2M
| $10.6K | ﹤0.01% |
1,515
+854
| +129% | +$9.89K |
|
|
FURY
2336
Fury Gold Mines
FURY
$98.9M
| $9.61K | ﹤0.01% |
24,322
| – | – |
|
2337
TRX Gold Corp
TRX
$255M
| $9.48K | ﹤0.01% |
30,486
| – | – |
|
2338
Seres Therapeutics
MCRB
$48M
| $9.17K | ﹤0.01% |
655
| – | – |
|
2339
Coherus Oncology
CHRS
$217M
| $9.01K | ﹤0.01% |
11,168
-317
| -3% | -$365 |
|
2340
Tenaya Therapeutics
TNYA
$168M
| $8.26K | ﹤0.01% |
+14,481
| New | +$14.3K |
|
2341
Leslie's
LESL
$11.6M
| $8.19K | ﹤0.01% |
+557
| New | +$17.1K |
|
2342
bioAffinity Technologies
BIAF
$4.15M
| $7.25K | ﹤0.01% |
930
| – | – |
|
2343
Rallybio
RLYB
$86.6M
| $6.54K | ﹤0.01% |
1,250
| – | – |
|
|
AMRN
2344
Amarin Corp
AMRN
$284M
| $6.42K | ﹤0.01% |
717
+110
| +18% | +$1.16K |
|
|
CISO
2345
CISO Global
CISO
$11.8M
| $5.91K | ﹤0.01% |
13,334
| – | – |
|
2346
Aclarion Warrant
ACONW
$44.8K
| $2.45K | ﹤0.01% |
78,400
| – | – |
|
|
AIM
2347
AIM ImmunoTech
AIM
$6.9M
| $2.45K | ﹤0.01% |
200
| – | – |
|
|
AUUDW
2348
DELISTED
Auddia Inc Warrants
AUUDW
| $628 | ﹤0.01% |
41,900
| – | – |
|
2349
Arbor Realty Trust
ABR
$960M
| – | – |
-13,494
| Closed | -$187K |
|
2350
Acadia Healthcare
ACHC
$3.17B
| – | – |
-12,784
| Closed | -$507K |
|
Similar funds
NAMI
CAPTRUST Financial Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, CAPTRUST Financial Advisors held 2,479 positions worth $39.9B, up 14% from $35B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
CAPTRUST Financial Advisors deployed $5.66B of net new capital in Q1 2025, opening 188 new positions and adding to 1,256 existing holdings. Its largest new stake was Cogent Communications: 539,084 shares worth $33.1M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Oracle, an estimated $67.6M trimmed.
- CAPTRUST Financial Advisors's largest Q1 2025 buy was Cogent Communications: 539,084 shares worth $33.1M.
- CAPTRUST Financial Advisors added most to Schwab US Large- Cap ETF in Q1 2025, an estimated $362M increase.
- CAPTRUST Financial Advisors's biggest Q1 2025 reduction was Oracle, cutting an estimated $67.6M.
- CAPTRUST Financial Advisors fully exited Castle Biosciences in Q1 2025, selling an estimated $5.74M.
- CAPTRUST Financial Advisors's ten largest holdings make up 25% of its $39.9B portfolio in Q1 2025.
- CAPTRUST Financial Advisors opened 188 new positions and closed 128 in Q1 2025.
- CAPTRUST Financial Advisors's portfolio value rose 14% quarter-over-quarter to $39.9B.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2025, filed 15 May 2025.